Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Neuroscience Letters
|
January 21, 2004
Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
Orit Bar Am, Tamar Amit, Moussa B H Youdim
Journal of Neurochemistry
|
July 20, 2007
Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro
Orit Bar-Am, Tamar Amit, Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 2, 2011
Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim
Orly Weinreb, Silvia Mandel, Orit Bar-Am, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 11, 2015
Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets
Orit Bar-Am, Tamar Amit, Moussa B Youdim, et al.
Acta Biomaterialia
|
April 8, 2023
Methacrylated fibrinogen hydrogels for 3D cell culture and delivery
Haneen Simaan-Yameen, Orit Bar-Am, Galit Saar, et al.
Current Drug Targets
|
January 28, 2012
Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
International Review of Neurobiology
|
October 6, 2011
A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
British Journal of Pharmacology
|
September 3, 2015
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
Annals of the New York Academy of Sciences
|
December 14, 2007
Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
Biomacromolecules
|
September 22, 2025
Evaluating Cross-Linking Efficiency and Cytocompatibility of Three Commonly Used Photoinitiators across Different Cell-Compatible Hydrogel Platforms
Aya Gavish Moscovitz, Haneen Simaan Yameen, Orit Bar-Am, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Neuroscience Letters
|
January 21, 2004
Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
Orit Bar Am, Tamar Amit, Moussa B H Youdim
Journal of Neurochemistry
|
July 20, 2007
Aminoindan and hydroxyaminoindan, metabolites of rasagiline and ladostigil, respectively, exert neuroprotective properties in vitro
Orit Bar-Am, Tamar Amit, Moussa B H Youdim
Journal of Neural Transmission (Vienna, Austria : 1996)
|
March 2, 2011
Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer's disease: a tribute to Moussa Youdim
Orly Weinreb, Silvia Mandel, Orit Bar-Am, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
April 11, 2015
Neuroprotective and neurorestorative potential of propargylamine derivatives in ageing: focus on mitochondrial targets
Orit Bar-Am, Tamar Amit, Moussa B Youdim, et al.
Acta Biomaterialia
|
April 8, 2023
Methacrylated fibrinogen hydrogels for 3D cell culture and delivery
Haneen Simaan-Yameen, Orit Bar-Am, Galit Saar, et al.
Current Drug Targets
|
January 28, 2012
Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
International Review of Neurobiology
|
October 6, 2011
A novel anti-Alzheimer's disease drug, ladostigil neuroprotective, multimodal brain-selective monoamine oxidase and cholinesterase inhibitor
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
British Journal of Pharmacology
|
September 3, 2015
Neuroprotective effects of multifaceted hybrid agents targeting MAO, cholinesterase, iron and β-amyloid in ageing and Alzheimer's disease
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
Annals of the New York Academy of Sciences
|
December 14, 2007
Induction of neurotrophic factors GDNF and BDNF associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy
Orly Weinreb, Tamar Amit, Orit Bar-Am, et al.
Biomacromolecules
|
September 22, 2025
Evaluating Cross-Linking Efficiency and Cytocompatibility of Three Commonly Used Photoinitiators across Different Cell-Compatible Hydrogel Platforms
Aya Gavish Moscovitz, Haneen Simaan Yameen, Orit Bar-Am, et al.
Page
of 7